about
Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing.Enterococcus faecalis bearing aggregation substance is resistant to killing by human neutrophils despite phagocytosis and neutrophil activationTherapeutic potential of adenosine kinase inhibitors.Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in miceCa2+-dependent muscle dysfunction caused by mutation of the Caenorhabditis elegans troponin T-1 geneStaphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.B lymphocyte-specific, Cre-mediated mutagenesis in miceSLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.Complement receptor 3 binds the Borrelia burgdorferi outer surface proteins OspA and OspB in an iC3b-independent manner.Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction.Widespread activation of microglial cells in the hippocampus of chronic epileptic rats correlates only partially with neurodegeneration.Adenosine modulation: a novel approach to analgesia and inflammation.Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers.The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E.
P2860
Q33295217-C1D1C8BA-B88D-42B9-9459-258544BFC345Q33877860-F7DC73F9-482C-4986-A312-E14F35999B7BQ34074761-3784179F-B248-4442-871E-BF2573BD6613Q35633511-7D886931-993A-4C97-8832-840AF1C08776Q35760681-1E7D46C4-A476-447C-AC16-A60CF2032FBDQ36256349-E5FAEA7E-7A5B-4970-95A9-228F61894347Q36300934-FE0A42B8-893F-444E-A549-4E4CABF93546Q36456719-19931ED0-EED4-4751-80B6-D851BF31BFFFQ37375694-02170CFC-0745-40F4-8356-7AA80F0045E5Q37839809-B20A7311-2C51-4C09-B2DF-C0707ABA75EEQ39719513-3D338619-DCBA-495E-800D-164938CDD0A2Q40244852-0349EE32-4824-492A-8D96-AF3B93E9BA72Q42523318-6F6796DA-7F99-4426-9611-18DFDE632B4DQ42539510-78CF199D-EC56-4874-A7F6-17A487942312Q47718174-A5E5DA9A-5C36-43A6-A3D2-856AF1646FE9Q48749495-694B1452-AED8-4F4B-AAA1-6B1845705A2EQ48826689-F38D1F36-C451-467B-AEA4-BAB21EA5D5F4Q51758607-C7C512CC-C571-484A-827F-C1A0AD880EE4Q52993512-1FAF69AB-912C-47BD-9E89-F83B96EEEF43
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The continuing saga of complement receptor type 3 (CR3)
@ast
The continuing saga of complement receptor type 3 (CR3)
@en
The continuing saga of complement receptor type 3 (CR3)
@nl
type
label
The continuing saga of complement receptor type 3 (CR3)
@ast
The continuing saga of complement receptor type 3 (CR3)
@en
The continuing saga of complement receptor type 3 (CR3)
@nl
prefLabel
The continuing saga of complement receptor type 3 (CR3)
@ast
The continuing saga of complement receptor type 3 (CR3)
@en
The continuing saga of complement receptor type 3 (CR3)
@nl
P356
P1476
The continuing saga of complement receptor type 3 (CR3)
@en
P2093
P356
10.1172/JCI118752
P407
P577
1996-07-01T00:00:00Z